Effectiveness of Internet-based Depression Treatment (EVIDENT) in Severe Depression
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02178631 |
Recruitment Status :
Completed
First Posted : July 1, 2014
Last Update Posted : May 27, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Severe Depressive Symptoms | Behavioral: Deprexis Other: CAU | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 163 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Study Start Date : | February 2013 |
Actual Primary Completion Date : | May 2014 |
Actual Study Completion Date : | May 2014 |

Arm | Intervention/treatment |
---|---|
Experimental: Deprexis
Online self-help
|
Behavioral: Deprexis
Online self-help |
Active Comparator: CAU
Care as usual
|
Other: CAU
Care as usual |
- Patient Health Questionnaire - 9 items (PHQ-9) [ Time Frame: Change from Baseline to post (3mths). ]
- Quick Inventory of Depressive Symptoms - Self-Rreport (QIDS-SR16) [ Time Frame: Baseline, post (3 mths), follow-up (6 mths) ]
- Generalized Anxiety Disorder - 7 (GAD-7) [ Time Frame: Baseline, post (3 mths), follow-up (6 mths) ]
- Patient Health Questionnaire - 15 items (PHQ-15) [ Time Frame: Baseline, post (3 mths), follow-up (6 mths) ]
- Short Form Health Survey - 12 (SF-12) [ Time Frame: Baseline, post (3 mths), follow-up (6 mths) ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Age between 18 and 65, ability to read German, willingness to participate in a telephone diagnostic interview, achieving a score of at least 15 on the PHQ-9 in an initial screening, and providing written informed consent
Exclusion Criteria:
- Lifetime diagnosis of schizophrenia or bipolar disorder (as determined by a telephone diagnostic interview) or current suicidality (as determined in a telephone interview)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02178631
Germany | |
Department of Psychiatry and Psychotherapy, University of Hamburg | |
Hamburg, Germany | |
Gaia AG | |
Hamburg, Germany | |
Department of Psychiatry and Psychotherapy, University of Luebeck | |
Luebeck, Germany | |
Switzerland | |
Department of Clinical Psychology and Psychotherapy, University of Bern | |
Bern, Switzerland |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Philipp Klein, Dr. med., University of Luebeck |
ClinicalTrials.gov Identifier: | NCT02178631 |
Other Study ID Numbers: |
EVIDENTplus |
First Posted: | July 1, 2014 Key Record Dates |
Last Update Posted: | May 27, 2015 |
Last Verified: | May 2015 |
Depression Behavioral Symptoms |